Gil Roth

President Pharma and Biopharma Outsourcing Association

Conference Day One - Wednesday 10 March 2027

11:00 AM KEYNOTE: HOW U.S POLICY IS CHANGING THE SUPPLY CHAIN RULES - PREPARING FOR TARRIFS, TRADE RESTICTIONS AND REGULATORY DISRUPTION

Escalating U.S. trade policy, proposed tariffs on pharmaceutical imports, and renewed discussions around Most Favoured Nation drug pricing are creating significant uncertainty across the global pharmaceutical industry. Resulting in manufacturers and their partners reassessing sourcing, production, pricing and market access strategies.

In this session, Gil Roth, President of the Pharma and Biopharma Outsourcing Association, will provide the latest update on evolving U.S. policy, examining how changes in trade and regulations are influencing pharmaceutical manufacturing, supply chains and global market dynamics. The discussion will explore the implications for Europe, including the potential impact on medicine availability, investment decisions and product launches.

Join us to discuss:

The latest developments in U.S. trade policy, tariffs and MFN pricing proposals and how pharmaceutical companies and CDMOs are adapting their supply chain, sourcing and manufacturing strategies in response.
What lessons the EMA and European policymakers can learn from the U.S. regulatory and pricing landscape.
How manufacturers can build greater resilience amid ongoing geopolitical and regulatory uncertainty.

Check out the incredible speaker line-up to see who will be joining Gil.

Download The Latest Agenda

In Partnership With:

QUESTIONS?

Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: +44 (0) 113 210 042
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk